The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis

Rikke Søgaard; Barbara Malene B Fischer; Jann Mortensen; Kristian Torben Rasmussen; Ulrik Lassen

doi:10.1016/j.jval.2012.09.007

The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis

Rikke Søgaard, Barbara Malene B Fischer, Jann Mortensen, Kristian Torben Rasmussen, Ulrik Lassen

Department of Clinical Physiology, Nuclear Medicine & PET

17 Citations (Scopus)

Abstract

To assess the expected costs and outcomes of alternative strategies for staging of lung cancer to inform a Danish National Health Service perspective about the most cost-effective strategy.

Original language	English
Journal	Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume	16
Issue number	1
Pages (from-to)	57-65
Number of pages	9
ISSN	1098-3015
DOIs	https://doi.org/10.1016/j.jval.2012.09.007
Publication status	Published - 2013

Keywords

Aged
Bronchoscopy
Carcinoma, Non-Small-Cell Lung
Cost-Benefit Analysis
Decision Trees
Denmark
Female
Humans
Lung Neoplasms
Male
Mediastinoscopy
Models, Economic
Multimodal Imaging
Neoplasm Metastasis
Neoplasm Staging
Positron-Emission Tomography
Quality of Life
Registries
Tomography, X-Ray Computed

Access to Document

10.1016/j.jval.2012.09.007

Cite this

Søgaard, R., Fischer, B. M. B., Mortensen, J., Rasmussen, K. T., & Lassen, U. (2013). The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16(1), 57-65. https://doi.org/10.1016/j.jval.2012.09.007

The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis. / Søgaard, Rikke; Fischer, Barbara Malene B; Mortensen, Jann et al.
In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 16, No. 1, 2013, p. 57-65.

Research output: Contribution to journal › Journal article › Research › peer-review

Søgaard, R, Fischer, BMB, Mortensen, J, Rasmussen, KT & Lassen, U 2013, 'The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis', Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 16, no. 1, pp. 57-65. https://doi.org/10.1016/j.jval.2012.09.007

@article{d6e0d2e913754f0589f0cdfcaa2adb6d,

title = "The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis",

abstract = "To assess the expected costs and outcomes of alternative strategies for staging of lung cancer to inform a Danish National Health Service perspective about the most cost-effective strategy.",

keywords = "Aged, Bronchoscopy, Carcinoma, Non-Small-Cell Lung, Cost-Benefit Analysis, Decision Trees, Denmark, Female, Humans, Lung Neoplasms, Male, Mediastinoscopy, Models, Economic, Multimodal Imaging, Neoplasm Metastasis, Neoplasm Staging, Positron-Emission Tomography, Quality of Life, Registries, Tomography, X-Ray Computed",

author = "Rikke S{\o}gaard and Fischer, {Barbara Malene B} and Jann Mortensen and Rasmussen, {Kristian Torben} and Ulrik Lassen",

year = "2013",

doi = "10.1016/j.jval.2012.09.007",

language = "English",

volume = "16",

pages = "57--65",

journal = "Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research",

issn = "1098-3015",

publisher = "Wiley-Blackwell Publishing, Inc",

number = "1",

}

TY - JOUR

T1 - The optimality of different strategies for supplemental staging of non-small-cell lung cancer

T2 - a health economic decision analysis

AU - Søgaard, Rikke

AU - Fischer, Barbara Malene B

AU - Mortensen, Jann

AU - Rasmussen, Kristian Torben

AU - Lassen, Ulrik

PY - 2013

Y1 - 2013

N2 - To assess the expected costs and outcomes of alternative strategies for staging of lung cancer to inform a Danish National Health Service perspective about the most cost-effective strategy.

AB - To assess the expected costs and outcomes of alternative strategies for staging of lung cancer to inform a Danish National Health Service perspective about the most cost-effective strategy.

KW - Aged

KW - Bronchoscopy

KW - Carcinoma, Non-Small-Cell Lung

KW - Cost-Benefit Analysis

KW - Decision Trees

KW - Denmark

KW - Female

KW - Humans

KW - Lung Neoplasms

KW - Male

KW - Mediastinoscopy

KW - Models, Economic

KW - Multimodal Imaging

KW - Neoplasm Metastasis

KW - Neoplasm Staging

KW - Positron-Emission Tomography

KW - Quality of Life

KW - Registries

KW - Tomography, X-Ray Computed

U2 - 10.1016/j.jval.2012.09.007

DO - 10.1016/j.jval.2012.09.007

M3 - Journal article

C2 - 23337216

SN - 1098-3015

VL - 16

SP - 57

EP - 65

JO - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

JF - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

IS - 1

ER -

The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis

Abstract

Keywords

Access to Document

Fingerprint

Cite this